Morning Social Media Outlook for Tuesday March 27 (ISTA, LNDC, CALM, MAPP)

In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis.

Provided by Social Market Analytics, here is the morning social media outlook for Tuesday, March 27.

Most Bullish

ISTA Pharma ISTA is trading up almost 8% on the current session. Earlier this morning, the company announced that it got a patent issued for Prolensa.

Landex LNDC is trading down slightly on the current session, but reported earnings yesterday that exceeded expectations.

Most Bearish

Cal-Maine Foods CALM is trading up slightly on the current session. The company reported earnings yesterday.

MAP Pharma MAPP is trading down almost 12% after the company announced that it had received a complete response letter from the FDA for Levadex.

Most Discussed

Apple AAPL nearly always sits atop this list. The company initiated a dividend last Monday and released its new iPad model earlier in the month.

MAP Pharma MAPP

Amazon AMZN is frequently discussed on social media, so its appearance here should be no surprise. Still, the online retailer announced that it would be building a new facility in Indiana that would employee roughly 1,000 people.

Google GOOG is also a popular company to discuss on social media. Google announced that it was thinking of reworking its plans for Google Wallet last week.

Arena Pharma ARNA is trading up 14% on the current session. Yesterday, the European Medicines Agency accepted a marketing authorization for Lorcaserin.

Interested in getting more information about stock trends on social media? Signup for the Social Market Analytics newsletter on their website.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLong IdeasNewsShort IdeasFDALegalMarketsTrading IdeasHealth CareMaterialsPharmaceuticalsSocial Market AnalyticsSpecialty Chemicalstwitter
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!